JPH0518831B2 - - Google Patents

Info

Publication number
JPH0518831B2
JPH0518831B2 JP58092637A JP9263783A JPH0518831B2 JP H0518831 B2 JPH0518831 B2 JP H0518831B2 JP 58092637 A JP58092637 A JP 58092637A JP 9263783 A JP9263783 A JP 9263783A JP H0518831 B2 JPH0518831 B2 JP H0518831B2
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
carboxamide
carbalkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58092637A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58216186A (ja
Inventor
Itsupen Yoahimu
Perutsuborun Eriizabeto
Purusu Barutaa
Sharaa Kurausu
Zoitaa Furiideru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS58216186A publication Critical patent/JPS58216186A/ja
Publication of JPH0518831B2 publication Critical patent/JPH0518831B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/16—Nitrogen atoms not forming part of a nitro radical acylated on said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP58092637A 1982-05-28 1983-05-27 グアニジノチアゾ−ル誘導体、それらの製造法およびそれらの薬剤としての用途 Granted JPS58216186A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3220118.4 1982-05-28
DE19823220118 DE3220118A1 (de) 1982-05-28 1982-05-28 Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
JPS58216186A JPS58216186A (ja) 1983-12-15
JPH0518831B2 true JPH0518831B2 (enExample) 1993-03-15

Family

ID=6164727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58092637A Granted JPS58216186A (ja) 1982-05-28 1983-05-27 グアニジノチアゾ−ル誘導体、それらの製造法およびそれらの薬剤としての用途

Country Status (6)

Country Link
US (1) US4581453A (enExample)
EP (1) EP0095640B1 (enExample)
JP (1) JPS58216186A (enExample)
AT (1) ATE17727T1 (enExample)
CA (1) CA1255299A (enExample)
DE (2) DE3220118A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0164204A1 (en) * 1984-05-12 1985-12-11 FISONS plc Novel pharmaceutically useful pyrimidines
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
DE3836184A1 (de) * 1988-10-24 1990-05-03 Bayer Ag Substituierte 2-aminothiazole
DE3839758A1 (de) * 1988-10-24 1990-04-26 Bayer Ag Substituierte 2-aminothiazole
US6132666A (en) * 1997-06-30 2000-10-17 Interface, Inc. Method for making formed fabric treatments
US6353006B1 (en) 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
NZ513639A (en) 1999-04-15 2004-02-27 Bristol Myers Squibb Co Cyclic protein tyrosine kinase inhibitors
DE19944342B4 (de) * 1999-09-16 2005-05-04 Primasoft Gmbh Anlage zur Aufnahme und/oder Wiedergabe von Sprache, Ton, Musik, Daten oder dergleichen Signalen
US20060122387A1 (en) * 2002-06-13 2006-06-08 Cti Europe S.R.L. Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells
CN101235018B (zh) * 2007-01-30 2011-05-04 重庆医药工业研究院有限责任公司 一种制备(1,4,5,6-四氢-2-嘧啶基)硫脲或其盐的改进方法
WO2016043260A1 (ja) * 2014-09-19 2016-03-24 塩野義製薬株式会社 環状グアニジンまたはアミジン化合物
WO2016098793A1 (ja) * 2014-12-17 2016-06-23 塩野義製薬株式会社 環状グアニジル基を有するチアゾール誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137317C (enExample) * 1967-11-10
DE1918070A1 (de) * 1969-04-09 1971-01-21 Thomae Gmbh Dr K Neue,an der Aminogruppe substituierte 2-Amino-5-nitro-thiazole und Verfahren zur Herstellung
DE2205745A1 (de) * 1972-02-08 1973-08-23 Thomae Gmbh Dr K Neue durch den n-cyaniminorest substituierten heterocyclen und verfahren zu ihrer herstellung
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives

Also Published As

Publication number Publication date
CA1255299A (en) 1989-06-06
JPS58216186A (ja) 1983-12-15
EP0095640A1 (de) 1983-12-07
US4581453A (en) 1986-04-08
DE3220118A1 (de) 1983-12-01
ATE17727T1 (de) 1986-02-15
EP0095640B1 (de) 1986-01-29
DE3361990D1 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
JP4531865B2 (ja) 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製
Bruneau et al. Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity
US4921998A (en) Substituted amino-5,6,7,8-tetrahydronaphthyl-oxyacetic acids, processes for their preparation and their use as medicaments
KR830001243B1 (ko) N-(페녹시알킬) 이미다졸 유도체의 제조방법
US4800211A (en) 5-methylthio-3-hydroxybenzo [b]thiophene-2-carboxamide derivatives as cyclooxygenase and lipoxygenase inhibitors
CS253702B2 (en) Process for preparing new 3-/1-imidazolylalkyl/indoles
MXPA06003247A (es) Oximas de arilo substituidas.
CN116262735B (zh) 新型氧代吡啶类化合物及其制备方法和用途
US4581453A (en) Guanidinothiazole derivatives containing alkylene bridges, and their use for influencing lipid metabolism
US4339583A (en) (Imidazolylmethyl)pyridine compounds as thromboxane synthetase inhibitors
CN101282926B (zh) S1p3受体拮抗剂
EP2838520B1 (en) Thromboxane receptor antagonists
JPH0717589B2 (ja) 新規１，３―ジカルボニル化合物およびその組成物
AU2022251900A9 (en) Composition for preventing or treating neurodegenerative disease comprising compound inducing expression of anti-aging gene klotho
CS229934B2 (en) Production method subst.indolylacryte acid derivative
JP5047629B2 (ja) ヒドラジドタイプの化合物及び心臓血管系疾患の治療のための製薬組成物の調製における該化合物の使用
US5041444A (en) Benzoxepin derivatives
US6255298B1 (en) Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases
UA64716C2 (en) Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
KR101061764B1 (ko) 신경보호효과를 가지는 피루베이트 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JPH0379337B2 (enExample)
US5356921A (en) Imidazolylphenol compounds, pharmaceutical compositions containing them, and processes for preparing such compounds and compositions
US20070066577A1 (en) Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
FR2641534A1 (fr) Nouveaux derives de glycine utiles comme medicaments antagonistes du thromboxane a2 et procede pour leur preparation
CN109879840B (zh) 4-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途